Skip to content
Profiles

Mary M Reilly, MD, MBE | CEB Co-Chair

University College London – National Hospital for Neurology and Neurosurgery and Queen Square Institute of Neurology
London, United Kingdom

Mary Reilly is Professor of Neurology and head of the Division of Clinical Neurology in UCL Queen Square Institute of Neurology. She is an outstanding clinical scientist in academic clinical neurology and is internationally recognized as a pioneer in inherited peripheral neuropathies.

Her major research interest are Charcot Marie Tooth disease (CMT) and hereditary transthyretin amyloidosis (hTTRA). Her research explores inherited peripheral neuropathies, a type of nerve damage, encompassing gene identification, pathogenetic studies, natural history studies, and biomarkers — especially MRI and clinical trials in CMT.

Throughout her career, Professor Reilly has demonstrated leadership, co-founding the Queen Square Clinical Trials Centre, a collaborative central research center for neurology and neurosurgery, the Queen Square Centre for Neuromuscular Diseases, where she is Co-Director, and subsequently helping to establish the International Centre for Genomic Medicine in Neuromuscular Diseases, where she is Co-Director. Professor Reilly also runs the largest CMT service in the UK with 6 clinics running every week.

Joined

2020

Therapy Type

Genetic Therapy; Natural History; Biomarkers; Clinical Trials

All types/subtypes of CMT